Swissx Genetics

Digging Deep into Hemp DNA and New Markets

Swissx Labs has launched a new division focused on genetic engineering. Our pioneering biotech team is advancing industrial hemp research, and taking our Genus Swissx hemp strain in exciting new directions.

A Global Leader in Ultra-High CBD / Low THC Strains

Genus Swissx will be even more hardy, produce more pure CBD, with minimal to zero THC and give more flavor than anything before it. Dr. Olaf Olson is working in the Swissx lab in Seoul, South Korea, and experimenting with thousands of possible mutations as well, enriching desirable cannabinoids and terpene profiles. Currently Swissx is distributing Swissx Melon (crossed with watermelon), Swissx Cherry Wine (crossed with black pepper and cherry plants), and Swissx Donald Trump.

Genus Swissx: Exempt from Recent Regulations

Products made from genus Swissx will be exempt from new regulations governing hemp and cannabis, clearing the way for a huge advantage as the field continues to grow exponentially. This will help with distribution to more regions internationally, as well as reduce customs fees, packaging constraints, and avoid regulatory hassles, smoothing the path for Swissx’s wellness products to get into the hands of consumers, and provide profit.

Swissx is also devoting tremendous research into the lesser known cannabinoid, CBG (or cannabigerol) and terpenes such as beta-myrcrene that have increased anti-inflammatory effects, and can fight sleep disorders and aid in overall well being. CBG is being studied for its antibacterial qualities and its effectiveness in treating glaucoma, Huntington’s Disease, inflammatory bowel disease, bladder dysfunction disorders, and its ability to block receptors that cause cancer cell growth. Studies on mice have shown a very exciting possibility to cure colorectal cancer in particular. Due to its appetite stimulant qualities, CBG may become non-psychotropic therapeutic option for cachexia, the muscle wasting and severe weight loss seen in late stage cancer and other diseases. Wherever the exciting discoveries about CBG take the medical world, Swissx is positioned to be ahead of the curve.

Groundbreaking Cloning Technologies

The biotech division has also developed new techniques in cloning pets--with its first project being a perfect clone of Alki David’s noble Doberman, Vader. The lessons learned from both plant and animal projects will fuel each other.

The biotech division and its projects will also be on display at the many sponsored entertainment and sports events planned including the Legends of American Music Hologram Tour kicking off in July 2019 and the Swissx Games in Gstaad and Malibu in 2020. Swissx Genetics projects will be featured in other media ventures with partners Hologram USA, FilmOn Networks and Octiive Music and at the Swissx Private Cannabis Lounge in Hollywood, CA.These efforts will increase awareness of the value and uses of quality CBD products, CBG’s amazing potential, and other scientific breakthroughs.

This product is not for use by or sale to persons under the age of 18. This product should be used only as directed on the label. It should not be used if you are pregnant or nursing. Consult with a physician before use if you have a serious medical condition or use prescription medications. A Doctor's advice should be sought before using this and any supplemental dietary product. All trademarks and copyrights are property of their respective owners and are not affiliated with nor do they endorse this product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. By using this site you agree to follow the Privacy Policy and all Terms & Conditions printed on this site. Void Where Prohibited By Law.

The cookie settings on this website are set to 'allow all cookies' to give you the very best experience. Please click Accept Cookies to continue to use the site.
You have successfully subscribed!